These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21470181)

  • 1. In silico prediction of cytochrome P450-mediated drug metabolism.
    Zhang T; Chen Q; Li L; Liu LA; Wei DQ
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of ADME/T properties: progress and challenge.
    Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):306. PubMed ID: 21470177
    [No Abstract]   [Full Text] [Related]  

  • 4. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions.
    Tan BH; Pan Y; Dong AN; Ong CE
    J Pharm Pharm Sci; 2017; 20(1):319-328. PubMed ID: 29145931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism.
    Ansede JH; Thakker DR
    J Pharm Sci; 2004 Feb; 93(2):239-55. PubMed ID: 14705182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of HT-ADME in drug discovery.
    Morgan D
    Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
    Tyzack JD; Kirchmair J
    Chem Biol Drug Des; 2019 Apr; 93(4):377-386. PubMed ID: 30471192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of cytochrome P450 drug interaction screening in drug discovery.
    Foti RS; Wienkers LC; Wahlstrom JL
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):145-58. PubMed ID: 20053168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico predictions of ADME-Tox properties: drug absorption.
    Geerts T; Vander Heyden Y
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico approaches for predicting ADME properties of drugs.
    Yamashita F; Hashida M
    Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
    Lu C; Liao M; Cohen L; Xia CQ
    Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico modeling of p450 substrates, inhibitors, activators, and inducers.
    DeLisle RK; Otten J; Rhodes S
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):396-416. PubMed ID: 21470185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.